CoChat

Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study

Open access
de Ritter, Rianneke, Sep, Simone J S, van der Kallen, Carla J H, Schram, Miranda T, Koster, Annemarie, Kroon, Abraham A, van Greevenbroek, Marleen M J, Eussen, Simone J P M, Dagnelie, Pieter C, de Jong, Marit, Vos, Rimke C, Woodward, Mark, Bots, Michiel L, Peters, Sanne A E, Stehouwer, Coen D A · 2019 · BMJ Open Diabetes Research & Care

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Objective: To investigate whether adverse differences in levels of cardiovascular risk factors in women than men, already established when comparing individuals with and without diabetes, are also present before type 2 diabetes onset. Research design and methods: In a population-based cohort study of individuals aged 40-75 years (n=3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated associations with cardiometabolic and lifestyle risk factors of (1) pre-diabetes and type 2 diabetes (reference category: normal glucose metabolism) and (2) among non-diabetic individuals, of continuous levels of hemoglobin A1c (HbA1c). Age-adjusted sex differences were analyzed using linear and logistic regression models with sex interaction terms. Results: In pre-diabetes, adverse differences in cardiometabolic risk factors were greater in women than men for systolic blood pressure (difference, 3.02 mm Hg; 95% CI:−0.26 to 6.30), high-density lipoprotein (HDL) cholesterol (difference, −0.10 mmol/L; 95% CI: −0.18 to −0.02), total-to-HDL cholesterol ratio (difference, 0.22; 95% CI: −0.01 to 0.44), triglycerides (ratio: 1.11; 95% CI: 1.01 to 1.22), and inflammation markers Z-score (ratio: 1.18; 95% CI: 0.98 to 1.41). In type 2 diabetes, these sex differences were similar in direction, and of greater magnitude. Additionally, HbA1c among non-diabetic individuals was more strongly associated with several cardiometabolic risk factors in women than men: per one per cent point increase, systolic blood pressure (difference, 3.58 mm Hg; 95% CI: −0.03 to 7.19), diastolic blood pressure (difference, 2.10 mm Hg; 95% CI: −0.02 to 4.23), HDL cholesterol (difference, −0.09 mmol/L; 95% CI: −0.19 to 0.00), and low-density lipoprotein cholesterol (difference, 0.26 mmol/L; 95% CI: 0.05 to 0.47). With regard to lifestyle risk factors, no consistent pattern was observed. Conclusion: Our results are consistent with the concept that the more adverse changes in cardiometabolic risk factors in women (than men) arise as a continuous process before the onset of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2019-000787

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Age-adjusted sex-specific mean differences of levels of cardiometabolic and lifestyle risk factors between (pre)diabetes and normal glucose metabolism as references category. Results are expressed as age-adjusted linear regression coefficients, which indicate mean differences in the levels of BMI and waist circumference, office blood pressure, lipid levels, and physical activity, geometric mean ratios in the levels of triglycerides, insulin sensitivity and markers of inflammation, and odds ratios in lifestyle risk factors. Circles represent comparisons within women and squares represent comparisons within men. Black lines represent 95% CIs. T2DM, type 2 diabetes mellitus; OSBP, office systolic blood pressure, ODBP, office diastolic blood pressure; Total chol, total cholesterol; PA, physical activity – mean number of stepping minutes perday; HOMA2-S, Homeostasis Model Assessment of insulin sensitivity.
Figure 1 Age-adjusted sex-specific mean differences of levels of cardiometabolic and lifestyle risk factors between (pre)diabetes and normal glucose metabolism as references category. Results are expressed as age-adjusted linear regression coefficients, which indicate mean differences in the levels of BMI and waist circumference, office blood pressure, lipid levels, and physical activity, geometric mean ratios in the levels of triglycerides, insulin sensitivity and markers of inflammation, and odds ratios in lifestyle risk factors. Circles represent comparisons within women and squares represent comparisons within men. Black lines represent 95% CIs. T2DM, type 2 diabetes mellitus; OSBP, office systolic blood pressure, ODBP, office diastolic blood pressure; Total chol, total cholesterol; PA, physical activity – mean number of stepping minutes perday; HOMA2-S, Homeostasis Model Assessment of insulin sensitivity.CC BY-NC · PubMed Central
Figure 2 Sex-specific associations (black circles: women, gray circles: men) of HbA1c with body mass index (A), waist circumference (B), hip circumference (C), waist-hip-ratio (D), HOMA2-S% (E), office systolic blood pressure (F), office diastolic blood pressure (G), total cholesterol (H), HDL cholesterol (I), total-to-HDL cholesterol (J), LDL cholesterol (K), triglycerides (L), markers of inflammation Z-score (M), mean number of stepping minutes per day (N) in participants without type 2 diabetes. Regression coefficients (beta) indicate the age-adjusted mean difference (95% CI) in cardiovascular risk factor levels per 1% point increase in HbA1c for women (black lines) and men (gray lines). *geometric mean ratios. †women to men ratio of geometric mean ratios. Mean differences that were statistically significantly different between the sexes are typed in bold. ··p<0.05 · p<0.10. HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HOMA2-S, homeostasis model assessment of insulin sensitivity; LDL, low-density lipoprotein.
Figure 2 Sex-specific associations (black circles: women, gray circles: men) of HbA1c with body mass index (A), waist circumference (B), hip circumference (C), waist-hip-ratio (D), HOMA2-S% (E), office systolic blood pressure (F), office diastolic blood pressure (G), total cholesterol (H), HDL cholesterol (I), total-to-HDL cholesterol (J), LDL cholesterol (K), triglycerides (L), markers of inflammation Z-score (M), mean number of stepping minutes per day (N) in participants without type 2 diabetes. Regression coefficients (beta) indicate the age-adjusted mean difference (95% CI) in cardiovascular risk factor levels per 1% point increase in HbA1c for women (black lines) and men (gray lines). *geometric mean ratios. †women to men ratio of geometric mean ratios. Mean differences that were statistically significantly different between the sexes are typed in bold. ··p<0.05 · p<0.10. HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HOMA2-S, homeostasis model assessment of insulin sensitivity; LDL, low-density lipoprotein.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 32

Metadata

Authors
de Ritter, R., Sep, S. J. S., van der Kallen, C. J. H., Schram, M. T., Koster, A., Kroon, A. A., van Greevenbroek, M. M. J., Eussen, S. J. P. M., Dagnelie, P. C., de Jong, M., Vos, R. C., Woodward, M., Bots, M. L., Peters, S. A. E., & Stehouwer, C. D. A.
Affiliations
  • Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands
  • Maastricht University Medical Centre (NL)
  • Maastricht University (NL)
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
  • Leiden University Medical Center (NL)
  • Johns Hopkins University (US)
  • University Medical Center Utrecht (NL)
  • The George Institute for Global Health (GB)
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2019-11
Volume
7
Issue
1
Pages
e000787
ISSN
2052-4897 (ISSN-L)
OpenAlex
W2983007116
Cited by
32
References
34
Citations by year
2026: 1 · 2025: 1 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 5 · 2020: 3
FWCI
2.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, cc-by-nc)
Funders
  • the Dutch Ministry of Economic Affairs
  • ZonMw (849200001)
  • Stichting De Weijerhorst
  • Health Foundation Limburg
  • the Pearl String Initiative Diabetes
  • Janssen-Cilag B.V.
  • Stichting Annadal
  • Sanofi-Aventis Netherlands B.V.
  • province of Limburg
  • Novo Nordisk Farma B.V.
  • European Regional Development Fund
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
diabetes mellitus, prediabetes, sex differences, cardiometabolic risk factors, type 2 diabetes, HbA1c, systolic blood pressure, HDL cholesterol, triglycerides, inflammatory markers, cardiovascular risk, Maastricht Study, women's health, lifestyle risk factors, dyslipidemia, hypertriglyceridemia, hyperinflammation, hypercoagulability
MeSH terms
Blood Glucose, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Life Style, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Prediabetic State, Prognosis, Prospective Studies, Risk Factors, Sex Factors, Triglycerides, Biomarkers, Body Mass Index, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study. https://app.cochat.ai/papers/10.1136/bmjdrc-2019-000787
The paper
de Ritter, R., Sep, S. J. S., van der Kallen, C. J. H., Schram, M. T., Koster, A., Kroon, A. A., van Greevenbroek, M. M. J., Eussen, S. J. P. M., Dagnelie, P. C., de Jong, M., Vos, R. C., Woodward, M., Bots, M. L., Peters, S. A. E., & Stehouwer, C. D. A. (2019). Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-000787

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.